Family Medicine · Manasquan, NJ
NPI
1750317889
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
235 Rt 71
Manasquan, NJ, 08736
Phone (732) 223-4300
Groups this clinician bills Medicare through
Medicare paid, 2024
$145K
2,259 services
Medicare patients, 2024
568
Average age 75
Drug cost, 2024
$762K
6,577 prescriptions
Company payments, 2025
$3,161
From 27 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kurt E Von Suskil was code 99214 (office e&m - established), 679 times for 368 patients. In total Kurt E Von Suskil billed 2,259 services in 48 codes, and Medicare paid $145K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-05-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 679 | 368 | $89.39 | $61K |
| 99213 Office E&M - Established | Office | 409 | 289 | $68.94 | $28K |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 252 | 252 | $19.97 | $5,033 |
| 93000 Electrocardiogram | Office | 167 | 149 | $10.02 | $1,674 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 114 | 114 | $136.56 | $16K |
| G0008 Administration of influenza virus vaccine | Office | 82 | 78 | $29.40 | $2,411 |
| 90662 Vaccine Product | Office | 79 | 75 | $80.44 | $6,355 |
| 96127 Behavioral Health Services | Office | 33 | 30 | $3.54 | $117 |
| 99212 Office E&M - Established | Office | 27 | 26 | $47.84 | $1,292 |
| 81003 Clinical Chemistry | Office | 25 | 20 | $2.20 | $55 |
| 90677 Vaccine Product | Office | 25 | 25 | $290.61 | $7,265 |
| G0009 Administration of pneumococcal vaccine | Office | 25 | 25 | $29.40 | $735 |
| G0438 Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 23 | 23 | $173.44 | $3,989 |
| 99497 Care Management/Coordination | Office | 19 | 19 | $78.30 | $1,488 |
| 87811 Immunoassay | Office | 13 | 12 | $40.55 | $527 |
By year: 2022 $194K for 2,742 services; 2023 $148K for 2,111 services; 2024 $145K for 2,259 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81003 Clinical Chemistry | 25 | 20 | $2.20 | $55 |
| 87811 Immunoassay | 13 | 12 | $40.55 | $527 |
Medicare prescription drug claims, 2024
In 2024, the drug Kurt E Von Suskil prescribed most often to Medicare patients was Rosuvastatin Calcium, with 517 prescriptions and refills. In total Kurt E Von Suskil wrote 6,577 Medicare prescriptions that cost $762K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Rosuvastatin Calcium Generic | 517 | 1,346 | 158 | $6,115 |
| Amlodipine Besylate Generic | 450 | 1,066 | 118 | $2,622 |
| Atorvastatin Calcium Generic | 412 | 1,048 | 116 | $5,188 |
| Hydrochlorothiazide Generic | 408 | 985 | 111 | $1,904 |
| Valsartan Generic | 351 | 829 | 90 | $9,215 |
| Levothyroxine Sodium Generic | 222 | 582 | 57 | $3,920 |
| Metoprolol Succinate Generic | 191 | 451 | 52 | $2,425 |
| Ezetimibe Generic | 171 | 419 | 55 | $3,901 |
| Losartan Potassium Generic | 132 | 336 | 40 | $1,257 |
| Lisinopril Generic | 124 | 324 | 30 | $876 |
| Ozempic Semaglutide | 112 | 176 | 19 | $163K |
| Pravastatin Sodium Generic | 98 | 206 | 22 | $1,016 |
| Sertraline Hcl Generic | 94 | 234 | 27 | $722 |
| Azithromycin Generic | 93 | 93 | 83 | $260 |
| Fluticasone Propionate Generic | 86 | 130 | 40 | $1,241 |
Brand drugs: 836 claims; generic drugs: 5,699 claims; opioid claims: 98.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kurt E Von Suskil $3,161 ($3,161 in general payments such as food, travel and fees) from 27 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $520.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 24 | $520 |
| Novo Nordisk Inc NVO | 22 | $383 |
| Abbvie Inc. ABBV | 16 | $375 |
| GlaxoSmithKline, LLC. GSK | 15 | $317 |
| Amgen Inc. AMGN | 23 | $288 |
| Lilly USA, LLC LLY | 11 | $197 |
| Pfizer Inc. PFE | 17 | $170 |
| Sanofi-Aventis U.S. LLC SNY | 2 | $148 |
| Boston Scientific Corporation BSX | 2 | $132 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 5 | $86.19 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.